Xavier Matias-Guiu Guia
Degree: PhD
973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/C-3039-2009
Groups
Publications
-
Megino-Luque C; Moiola CP; Molins-Escuder C; López-Gil C; Gil-Moreno A; Matias-Guiu X; Colas E; Eritja N
Small-Molecule Inhibitors (SMIs) as an Effective Therapeutic Strategy for Endometrial Cancer.
Cancers 12 1-26. .
-
Da Cruz Paula A; da Silva, EM; Segura, SE; Pareja, F; Bi, R; Selenica, P; Kim, SH; Ferrando, L; Vahdatinia, M; Soslow, RA; Vidal, A; Gatius, S; Przybycin, CG; Abu-Rustum, NR; Matias-Guiu, X; Rubin, BP; Reis, JS; DeLair, DF; Weigelt, B
Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary.
Modern Pathology 33 1606-1617. .
-
Damaso, E; Gonzalez-Acosta, M; Vargas-Parra, G; Navarro, M; Balmaña J; Ramon Y Cajal T; Tuset, N; Thompson, BA; Marin, F; Fernandez, A; Gomez, C; Velasco À; Solanes, A; Iglesias, S; Urgel, G; Lopez, C; del Valle, J; Campos, O; Santacana, M; Matias-Guiu, X; Lazaro, C; Valle, L; Brunet, J; Pineda, M; Capella, G
Comprehensive Constitutional Genetic and Epigenetic Characterization of Lynch-Like Individuals.
Cancers 12 1-32. .
-
Mayo-de-las-Casas, C; Velasco, A; Sanchez, D; Martínez-Bueno A; Garzón-Ibáñez M; Gatius, S; Ruiz-Mir?, M; Gonzalez-Tallada, X; Llordella, I; Tresserra, F; Rodríguez S; Aldeguer, E; Roman-Canal, B; Bertran-Alamillo, J; García-Peláez B; Rosell, R; Molina-Vila, MA; Matias-Guiu, X
Detection of somatic mutations in peritoneal lavages and plasma of endometrial cancer patients: a proof-of-concept study.
INTERNATIONAL JOURNAL OF CANCER 147 277-284. .
-
Matias-Guiu, Xavier
Nuevos tiempos, nuevas prioridades.
Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia 53 137-137. .
-
Alonso-Alconada, L; de la Fuente, A; Santacana, M; Ferreiros, A; Lopez-Lopez, R; Matias-Guiu, X; Abal, M
Biomimetic device and foreign body reaction cooperate for efficient tumour cell capture in murine advanced ovarian cancer.
DISEASE MODELS & MECHANISMS 13 -. .
-
Lahiguera Á; Hyroššová P; Figueras A; Garzón D; Moreno R; Soto-Cerrato V; McNeish I; Serra V; Lazaro C; Barretina P; Brunet J; Menéndez J; Matias-Guiu X; Vidal A; Villanueva A; Taylor-Harding B; Tanaka H; Orsulic S; Junza A; Yanes O; Muñoz-Pinedo C; Palomero L; Pujana MÀ; Perales JC; Viñals F
Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors.
Embo Molecular Medicine 12 -. .
-
Moreno, S; Maiques, O; Gatius, S; Vea, A; Barrera, J; Barcelo, C; Santacana, M; Soria, X; Matias-Guiu, X; Marti, RM
Descriptive study of naevus involution in a series of 74 patients with atypical naevus syndrome under SIAscopy digital follow-up
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 34 1210-1217. .
-
Reijnen, C; Gogou, E; Visser NCM; Engerud, H; Ramjith, J; van der Putten LJM; van de Vijver K; Santacana, M; Bronsert, P; Bulten, J; Hirschfeld, M; Colas, E; Gil-Moreno, A; Reques, A; Mancebo, G; Krakstad, C; Trovik, J; Haldorsen, IS; Huvila, J; Koskas, M; Weinberger, V; Bednarikova, M; Hausnerova, J; van der Wurff AAM; Matias-Guiu, X; Amant, F; ENITEC Consortium; Massuger LFAG; Snijders MPLM; Küsters-Vandevelde HVN; Lucas PJF; Pijnenborg JMA
Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study.
PLOS MEDICINE 17 -. .
-
Delgado-Garcia, M; Weynand, B; Gomez-Izquierdo, L; Hernandez, MJ; Blanco, AM; Varela, M; Matias-Guiu, X; Nadal, E; Marquez-Lobo, B; Alarcão A; de Alava, E; Biscuola, M
Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed paraffin-embedded tissue of non-small cell lung cancer.
Bmc Cancer 20 275-275. .
-
Matias-Guiu, X; Stanta, G; Carneiro, F; Ryska, A; Hoefler, G; Moch, H; European Society of Pathology (ESP)
The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology.
VIRCHOWS ARCHIV 476 491-497. .
-
Mendaza, S; Fernandez-Irigoyen, J; Santamaria, E; Zudaire, T; Guarch, R; Guerrero-Setas, D; Vidal, A; Santos-Salas, J; Matias-Guiu, X; Ausin, K; Díaz de Cerio MJ; Martin-Sanchez, E
Absence of Nuclear p16 Is a Diagnostic and Independent Prognostic Biomarker in Squamous Cell Carcinoma of the Cervix.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 21 -. .
Projects
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- EPH Receptor Signaling in Endometrial Cancer
- Ajuts per a la contractació de personal investigador novell (FI)
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
